Skip to content
healthcare.dev

Febuxostat

NDC 59651-113, Febuxostat, tablet, from Aurobindo Pharma Limited.

Product NDC
59651-113
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210741
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59651-113 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FEBUXOSTAT40 mg/1

Pharmacologic classes

Xanthine Oxidase Inhibitor [EPC]; Xanthine Oxidase Inhibitors [MoA]

Package NDCNDC-11Package
59651-113-0559651011305500 TABLET in 1 BOTTLE (59651-113-05)
59651-113-305965101133030 TABLET in 1 BOTTLE (59651-113-30)
59651-113-905965101139090 TABLET in 1 BOTTLE (59651-113-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/04f80eb2-8171-4e18-93e4-514440e84b75
  • NADAC price for package 59651011330

    GET /v1/drugs/nadac/59651011330

Use it

Look up 59651-113 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59651-113 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59651-113. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.